GSTP1 and astrocytoma (excluding glioblastoma): biopsy specimens from malignant glioma patients (astrocytoma, anaplastic astrocytoma, glioblastoma multiforme, oligodendroglioma, glioma); MGMT and GSTP1 overexpression are independently associated with BCNU resistance, greatest resistance seen with co-expression